| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyCellularComponent | cytoplasmic region | 1.13e-04 | 360 | 64 | 7 | GO:0099568 | |
| Domain | Spectrin | 8.70e-07 | 23 | 61 | 4 | PF00435 | |
| Domain | Spectrin_repeat | 2.30e-06 | 29 | 61 | 4 | IPR002017 | |
| Domain | Spectrin/alpha-actinin | 3.46e-06 | 32 | 61 | 4 | IPR018159 | |
| Domain | SPEC | 3.46e-06 | 32 | 61 | 4 | SM00150 | |
| Domain | Caskin_C | 1.05e-05 | 2 | 61 | 2 | IPR032117 | |
| Domain | Caskin-tail | 1.05e-05 | 2 | 61 | 2 | PF16632 | |
| Domain | SH3 | 7.29e-05 | 216 | 61 | 6 | PS50002 | |
| Domain | SH3_domain | 8.07e-05 | 220 | 61 | 6 | IPR001452 | |
| Domain | PH | 2.88e-04 | 278 | 61 | 6 | SM00233 | |
| Domain | PH_DOMAIN | 2.94e-04 | 279 | 61 | 6 | PS50003 | |
| Domain | PH_domain | 2.99e-04 | 280 | 61 | 6 | IPR001849 | |
| Domain | Copine | 3.72e-04 | 9 | 61 | 2 | PF07002 | |
| Domain | Copine | 3.72e-04 | 9 | 61 | 2 | IPR010734 | |
| Domain | SH3 | 6.94e-04 | 216 | 61 | 5 | SM00326 | |
| Domain | ARM-type_fold | 8.20e-04 | 339 | 61 | 6 | IPR016024 | |
| Domain | PH | 9.03e-04 | 229 | 61 | 5 | PF00169 | |
| Domain | RhoGEF | 1.43e-03 | 68 | 61 | 3 | SM00325 | |
| Domain | RhoGEF | 1.55e-03 | 70 | 61 | 3 | PF00621 | |
| Domain | DH_2 | 1.55e-03 | 70 | 61 | 3 | PS50010 | |
| Domain | DH-domain | 1.62e-03 | 71 | 61 | 3 | IPR000219 | |
| Domain | - | 1.62e-03 | 71 | 61 | 3 | 1.20.900.10 | |
| Domain | - | 1.70e-03 | 391 | 61 | 6 | 2.30.29.30 | |
| Domain | CRAL_TRIO | 2.12e-03 | 21 | 61 | 2 | PF00650 | |
| Domain | Actinin_actin-bd_CS | 2.54e-03 | 23 | 61 | 2 | IPR001589 | |
| Domain | - | 2.54e-03 | 23 | 61 | 2 | 3.40.525.10 | |
| Domain | ACTININ_2 | 2.54e-03 | 23 | 61 | 2 | PS00020 | |
| Domain | ACTININ_1 | 2.54e-03 | 23 | 61 | 2 | PS00019 | |
| Domain | PH_dom-like | 2.62e-03 | 426 | 61 | 6 | IPR011993 | |
| Domain | SH3_2 | 2.80e-03 | 86 | 61 | 3 | IPR011511 | |
| Domain | SH3_2 | 2.80e-03 | 86 | 61 | 3 | PF07653 | |
| Domain | SEC14 | 3.00e-03 | 25 | 61 | 2 | SM00516 | |
| Domain | CRAL_TRIO | 3.49e-03 | 27 | 61 | 2 | PS50191 | |
| Domain | CRAL-TRIO_dom | 3.76e-03 | 28 | 61 | 2 | IPR001251 | |
| Pathway | REACTOME_FOXO_MEDIATED_TRANSCRIPTION | 5.45e-05 | 22 | 48 | 3 | MM15656 | |
| Pathway | REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_OXIDATIVE_STRESS_METABOLIC_AND_NEURONAL_GENES | 1.41e-04 | 30 | 48 | 3 | M27941 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | FOXO3 AMER1 INTS12 TRIO CASKIN2 IQSEC2 MACF1 PLEKHM3 MTREX DDX41 UTRN VIRMA DNAH7 | 4.92e-09 | 861 | 64 | 13 | 36931259 |
| Pubmed | 1.28e-08 | 151 | 64 | 7 | 17043677 | ||
| Pubmed | 2.56e-07 | 234 | 64 | 7 | 36243803 | ||
| Pubmed | IPO5 PTGES2 ABCA2 TRIO KALRN IQSEC2 CEP57L1 POLR1C MACF1 YY1AP1 KPNA6 UTRN SLC4A3 | 5.12e-07 | 1285 | 64 | 13 | 35914814 | |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | IPO5 USP45 VPS35 POLR1C ATXN3 RIMBP2 DTNBP1 DDX41 UTRN AKAP7 EFTUD2 | 2.04e-06 | 1005 | 64 | 11 | 19615732 |
| Pubmed | 2.49e-06 | 638 | 64 | 9 | 33239621 | ||
| Pubmed | Interaction of ataxin-3 with huntingtin-associated protein 1 through Josephin domain. | 3.33e-06 | 2 | 64 | 2 | 21386698 | |
| Pubmed | Central FoxO3a and FoxO6 expression is down-regulated in obesity induced diabetes but not in aging. | 3.33e-06 | 2 | 64 | 2 | 22187289 | |
| Pubmed | Kalirin and Trio proteins serve critical roles in excitatory synaptic transmission and LTP. | 3.33e-06 | 2 | 64 | 2 | 26858404 | |
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | 8.09e-06 | 394 | 64 | 7 | 27248496 | |
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 10822175 | ||
| Pubmed | FoxO6, a novel member of the FoxO class of transcription factors with distinct shuttling dynamics. | 9.99e-06 | 3 | 64 | 2 | 12857750 | |
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 31801062 | ||
| Pubmed | Mutations in FAM50A suggest that Armfield XLID syndrome is a spliceosomopathy. | 9.99e-06 | 3 | 64 | 2 | 32703943 | |
| Pubmed | Dendritic spine morphology and memory formation depend on postsynaptic Caskin proteins. | 9.99e-06 | 3 | 64 | 2 | 31727973 | |
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 11751052 | ||
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 12040031 | ||
| Pubmed | IPO5 MYBBP1A TRIO KALRN CASKIN1 IQSEC2 VPS35 MACF1 RIMBP2 CPNE4 UTRN VIRMA | 1.02e-05 | 1431 | 64 | 12 | 37142655 | |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | 1.50e-05 | 605 | 64 | 8 | 28977666 | |
| Pubmed | 1.54e-05 | 1014 | 64 | 10 | 32416067 | ||
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | 1.64e-05 | 807 | 64 | 9 | 30575818 | |
| Pubmed | 1.84e-05 | 622 | 64 | 8 | 14574404 | ||
| Pubmed | Treacher Collins syndrome: a clinical and molecular study based on a large series of patients. | 2.00e-05 | 4 | 64 | 2 | 25790162 | |
| Pubmed | 2.00e-05 | 4 | 64 | 2 | 16326148 | ||
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | MMS22L MYBBP1A VPS35 POLR1C UFL1 KPNA6 HERC1 MTREX DDX41 SON EFTUD2 | 2.05e-05 | 1284 | 64 | 11 | 17353931 |
| Pubmed | Muscle developmental defects in heterogeneous nuclear Ribonucleoprotein A1 knockout mice. | 2.33e-05 | 30 | 64 | 3 | 28077597 | |
| Pubmed | Assembly of high order G alpha q-effector complexes with RGS proteins. | 3.32e-05 | 5 | 64 | 2 | 18936096 | |
| Pubmed | 3.59e-05 | 497 | 64 | 7 | 23414517 | ||
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | IPO5 MYBBP1A VPS35 POLR1C MACF1 UFL1 KPNA6 MTREX DDX41 SON EFTUD2 | 4.98e-05 | 1415 | 64 | 11 | 28515276 |
| Pubmed | 4.98e-05 | 6 | 64 | 2 | 22666460 | ||
| Pubmed | FoxO transcription factors; Regulation by AKT and 14-3-3 proteins. | 4.98e-05 | 6 | 64 | 2 | 21708191 | |
| Pubmed | FoxO transcription factors suppress Myc-driven lymphomagenesis via direct activation of Arf. | 4.98e-05 | 6 | 64 | 2 | 17974917 | |
| Pubmed | MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development. | 5.17e-05 | 358 | 64 | 6 | 32460013 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | IPO5 MYBBP1A GUCY1B2 TRIO VPS35 UFL1 KPNA6 FGD5 MTREX DDX41 EFTUD2 | 5.30e-05 | 1425 | 64 | 11 | 30948266 |
| Pubmed | 6.48e-05 | 963 | 64 | 9 | 28671696 | ||
| Pubmed | METTL3 protects METTL14 from STUB1-mediated degradation to maintain m6 A homeostasis. | 6.86e-05 | 231 | 64 | 5 | 36597993 | |
| Pubmed | Human nuclear RNAi-defective 2 (NRDE2) is an essential RNA splicing factor. | 6.96e-05 | 7 | 64 | 2 | 30538148 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 8.56e-05 | 774 | 64 | 8 | 15302935 | |
| Pubmed | Systematic Analysis of Human Protein Phosphatase Interactions and Dynamics. | 8.76e-05 | 573 | 64 | 7 | 28330616 | |
| Pubmed | Mutant huntingtin impairs PNKP and ATXN3, disrupting DNA repair and transcription. | 9.27e-05 | 8 | 64 | 2 | 30994454 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | 9.65e-05 | 582 | 64 | 7 | 20467437 | |
| Pubmed | 1.01e-04 | 251 | 64 | 5 | 27507650 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | 1.03e-04 | 1024 | 64 | 9 | 24711643 | |
| Pubmed | 1.05e-04 | 407 | 64 | 6 | 12693553 | ||
| Pubmed | 1.19e-04 | 9 | 64 | 2 | 10366569 | ||
| Pubmed | 1.19e-04 | 9 | 64 | 2 | 10525473 | ||
| Pubmed | 1.19e-04 | 9 | 64 | 2 | 10888652 | ||
| Pubmed | 1.19e-04 | 9 | 64 | 2 | 9366553 | ||
| Pubmed | 1.19e-04 | 9 | 64 | 2 | 11389849 | ||
| Pubmed | Changing expression and subcellular distribution of karyopherins during murine oogenesis. | 1.19e-04 | 9 | 64 | 2 | 26399853 | |
| Pubmed | Active nuclear import of human immunodeficiency virus type 1 preintegration complexes. | 1.19e-04 | 9 | 64 | 2 | 1631159 | |
| Pubmed | 1.19e-04 | 9 | 64 | 2 | 9430674 | ||
| Pubmed | 1.19e-04 | 9 | 64 | 2 | 10860744 | ||
| Pubmed | Viral protein R regulates nuclear import of the HIV-1 pre-integration complex. | 1.19e-04 | 9 | 64 | 2 | 9463369 | |
| Pubmed | 1.19e-04 | 9 | 64 | 2 | 12414950 | ||
| Pubmed | 1.19e-04 | 9 | 64 | 2 | 8105392 | ||
| Pubmed | 1.19e-04 | 9 | 64 | 2 | 11035935 | ||
| Pubmed | 1.19e-04 | 9 | 64 | 2 | 9275210 | ||
| Pubmed | Characterization of the nuclear import pathway for HIV-1 integrase. | 1.19e-04 | 9 | 64 | 2 | 11278458 | |
| Pubmed | 1.19e-04 | 9 | 64 | 2 | 12368302 | ||
| Pubmed | 1.49e-04 | 10 | 64 | 2 | 22228203 | ||
| Pubmed | Nuclear Functions of Nucleolin through Global Proteomics and Interactomic Approaches. | 1.52e-04 | 145 | 64 | 4 | 27049334 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | NAA35 MYBBP1A VPS35 POLR1C MACF1 MTREX DDX41 UTRN SON EFTUD2 | 1.72e-04 | 1353 | 64 | 10 | 29467282 |
| Pubmed | HIV-1 nuclear import: matrix protein is back on center stage, this time together with Vpr. | 1.81e-04 | 11 | 64 | 2 | 9562972 | |
| Pubmed | The functional interactome landscape of the human histone deacetylase family. | 1.95e-04 | 289 | 64 | 5 | 23752268 | |
| Pubmed | 1.96e-04 | 653 | 64 | 7 | 22586326 | ||
| Pubmed | 2.17e-04 | 12 | 64 | 2 | 28213137 | ||
| Pubmed | 2.25e-04 | 469 | 64 | 6 | 37314180 | ||
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | 2.41e-04 | 475 | 64 | 6 | 31040226 | |
| Pubmed | MYBBP1A TNRC18 AMER1 INTS12 CLCN5 VPS35 COQ6 MACF1 PHF14 SLC4A3 | 2.86e-04 | 1442 | 64 | 10 | 35575683 | |
| Pubmed | STING-Mediated IFI16 Degradation Negatively Controls Type I Interferon Production. | 2.95e-04 | 316 | 64 | 5 | 31665637 | |
| Pubmed | 3.53e-04 | 720 | 64 | 7 | 16381901 | ||
| Pubmed | 3.59e-04 | 722 | 64 | 7 | 15489336 | ||
| Pubmed | 3.70e-04 | 332 | 64 | 5 | 37433992 | ||
| Pubmed | 3.80e-04 | 76 | 64 | 3 | 27542412 | ||
| Pubmed | 3.85e-04 | 1497 | 64 | 10 | 31527615 | ||
| Pubmed | 3.93e-04 | 16 | 64 | 2 | 16376864 | ||
| Pubmed | 4.07e-04 | 339 | 64 | 5 | 30415952 | ||
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | 4.18e-04 | 341 | 64 | 5 | 32971831 | |
| Pubmed | 4.41e-04 | 80 | 64 | 3 | 11991638 | ||
| Pubmed | STUB1 is targeted by the SUMO-interacting motif of EBNA1 to maintain Epstein-Barr Virus latency. | 4.42e-04 | 192 | 64 | 4 | 32176739 | |
| Pubmed | 4.51e-04 | 750 | 64 | 7 | 11230166 | ||
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | 4.84e-04 | 759 | 64 | 7 | 35915203 | |
| Pubmed | The protein network surrounding the human telomere repeat binding factors TRF1, TRF2, and POT1. | 4.86e-04 | 197 | 64 | 4 | 20811636 | |
| Pubmed | The Deubiquitinase USP37 Regulates Chromosome Cohesion and Mitotic Progression. | 5.09e-04 | 84 | 64 | 3 | 26299517 | |
| Pubmed | 5.25e-04 | 201 | 64 | 4 | 34917906 | ||
| Pubmed | Ubiquitin-Independent Disassembly by a p97 AAA-ATPase Complex Drives PP1 Holoenzyme Formation. | 5.41e-04 | 361 | 64 | 5 | 30344098 | |
| Pubmed | Transcriptome analysis of mouse stem cells and early embryos. | 5.55e-04 | 363 | 64 | 5 | 14691545 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | 5.80e-04 | 1294 | 64 | 9 | 30804502 | |
| Pubmed | 6.20e-04 | 20 | 64 | 2 | 21689717 | ||
| Pubmed | Recruitment of the human TREX complex to mRNA during splicing. | 6.20e-04 | 20 | 64 | 2 | 15998806 | |
| Pubmed | 6.32e-04 | 794 | 64 | 7 | 11076863 | ||
| Pubmed | HAPSTR1 localizes HUWE1 to the nucleus to limit stress signaling pathways. | 6.39e-04 | 571 | 64 | 6 | 37167062 | |
| Pubmed | 6.62e-04 | 1049 | 64 | 8 | 27880917 | ||
| Pubmed | 6.75e-04 | 215 | 64 | 4 | 30462309 | ||
| Pubmed | Identification of cellular proteins required for replication of human immunodeficiency virus type 1. | 6.84e-04 | 21 | 64 | 2 | 22404213 | |
| Pubmed | 6.84e-04 | 21 | 64 | 2 | 24923560 | ||
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | 6.95e-04 | 807 | 64 | 7 | 22681889 | |
| Pubmed | 7.25e-04 | 1335 | 64 | 9 | 29229926 | ||
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 7.35e-04 | 220 | 64 | 4 | 35785414 | |
| Interaction | YWHAH interactions | FOXO3 ABCA2 AMER1 INTS12 FOXO6 TRIO CASKIN2 IQSEC2 MACF1 PLEKHM3 HERC1 MTREX UTRN VIRMA DNAH7 EFTUD2 | 1.84e-07 | 1102 | 63 | 16 | int:YWHAH |
| Interaction | KALRN interactions | 5.45e-07 | 96 | 63 | 6 | int:KALRN | |
| Interaction | FOXO3B interactions | 5.78e-07 | 6 | 63 | 3 | int:FOXO3B | |
| Interaction | YWHAG interactions | FOXO3 AMER1 FOXO6 CASKIN2 IQSEC2 MACF1 PLEKHM3 MTREX DDX41 UTRN VIRMA DNAH7 SON EFTUD2 | 2.42e-05 | 1248 | 63 | 14 | int:YWHAG |
| Interaction | H2AC4 interactions | 2.62e-05 | 506 | 63 | 9 | int:H2AC4 | |
| Interaction | RPL31 interactions | IPO5 NAA35 MYBBP1A ATAD5 MACF1 UFL1 MTREX DDX41 VIRMA EFTUD2 | 4.55e-05 | 680 | 63 | 10 | int:RPL31 |
| Interaction | PSMD13 interactions | 4.64e-05 | 306 | 63 | 7 | int:PSMD13 | |
| Interaction | ABCF2 interactions | 4.81e-05 | 209 | 63 | 6 | int:ABCF2 | |
| Interaction | CSE1L interactions | 5.46e-05 | 314 | 63 | 7 | int:CSE1L | |
| Interaction | CDC5L interactions | IPO5 MYBBP1A TRIO KALRN MACF1 UFL1 MTREX DDX41 VIRMA SON EFTUD2 | 6.14e-05 | 855 | 63 | 11 | int:CDC5L |
| Cytoband | Ensembl 112 genes in cytogenetic band chr6q16 | 6.79e-05 | 56 | 64 | 3 | chr6q16 | |
| Cytoband | 6q16.1 | 2.89e-04 | 18 | 64 | 2 | 6q16.1 | |
| GeneFamily | Copines | 2.25e-04 | 9 | 46 | 2 | 829 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 6.30e-04 | 66 | 46 | 3 | 722 | |
| GeneFamily | Armadillo repeat containing|Importins | 9.44e-04 | 18 | 46 | 2 | 596 | |
| Coexpression | GSE23505_IL6_IL1_VS_IL6_IL1_TGFB_TREATED_CD4_TCELL_DN | 9.50e-06 | 200 | 64 | 6 | M7861 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Mesenchymal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.44e-06 | 182 | 64 | 5 | ffe500d78a89dc6b4d05bab1664e7f30c94fb8d9 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Mesenchymal-Pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.79e-06 | 184 | 64 | 5 | 94748f63947db79a6b4540e3090a63689fdd9452 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Mesenchymal-brain_pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.79e-06 | 184 | 64 | 5 | 819b277ecced7b415e363c7e7ddbc6f3b2d296de | |
| ToppCell | 3'_v3-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue | 4.28e-05 | 135 | 64 | 4 | ae2d3a42e567b5bade304c0caa497eb725be3565 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c05-ZNF683|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.70e-05 | 157 | 64 | 4 | a633fb8e7a009490c6002bf272eceaf317f27af6 | |
| ToppCell | metastatic_Brain-Fibroblasts-Smooth_muscle_cells|metastatic_Brain / Location, Cell class and cell subclass | 9.56e-05 | 166 | 64 | 4 | 0da2c6ea1e62f1aafabafbbfbbcc6f7011739346 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.05e-04 | 170 | 64 | 4 | e20568c8f3f17d94de78229617eb2f7e4c5af2bc | |
| ToppCell | Control-Fibroblasts-Pericytes|Control / group, cell type (main and fine annotations) | 1.07e-04 | 171 | 64 | 4 | 080003f698f867935c2bfc55d241d3650f45a0ab | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.42e-04 | 184 | 64 | 4 | 8fd8bd3d28d0ee6f0ef1f14e354d8eaf63a8081b | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Mesenchymal-brain_pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-04 | 185 | 64 | 4 | 98547c1b1828b76da810ed86082182afaaacdb3f | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Mesenchymal-Pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-04 | 185 | 64 | 4 | 5f5df92b328be396941b5812d00454b5ff927d30 | |
| ToppCell | 3'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.48e-04 | 186 | 64 | 4 | d3509a579871ba6a8c4edd6137b28f271c9dbe70 | |
| ToppCell | 10x3'2.3-week_17-19-Endothelial-stroma-proliferating_EC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.48e-04 | 186 | 64 | 4 | a844d4f79e0ad5d6c60a4488ffd8f4f21b7eed04 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.51e-04 | 187 | 64 | 4 | 86250acf088ec0c4800a0dfa031b0d4f7e52c342 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 1.54e-04 | 188 | 64 | 4 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | facs-Brain_Myeloid-Striatum-3m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-04 | 189 | 64 | 4 | 6dd4ec5ce4beb856f0d2d1654e3c4676d1d63736 | |
| ToppCell | facs-Brain_Myeloid-Striatum-3m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-04 | 189 | 64 | 4 | 3ae479ec7e00c57127cbe51a398329b10ca9848c | |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_D_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-04 | 189 | 64 | 4 | fcc3713e8200d51074f709f3360fb36efb0a639f | |
| ToppCell | Mesenchymal-pericyte_cell|World / Lineage, Cell type, age group and donor | 1.57e-04 | 189 | 64 | 4 | d7ed96add29f219183c802895fbff519b627f635 | |
| ToppCell | facs-Brain_Myeloid-Striatum-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-04 | 189 | 64 | 4 | 875df61ee48baa5142ba4d2427bdec1c53e5a828 | |
| ToppCell | facs-Brain_Myeloid-Striatum-3m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-04 | 189 | 64 | 4 | 97ef5215d841ff366a3e3682cd9bd04100cbfde0 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.64e-04 | 191 | 64 | 4 | 04c4d454b57e29a8d1dcdeb4678ce71bdc29b77b | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-04 | 193 | 64 | 4 | 06b65110db974f4ef90d3511ff34428976a52c9c | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-04 | 193 | 64 | 4 | be28070c049e7cb68bcd54f582226eb2f5e4bc1c | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-04 | 193 | 64 | 4 | 0c652ebe22ce5d2927599dd97ef1920547858395 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-04 | 193 | 64 | 4 | 8689a70a33a7c3823dc647d41ac0160e7c3ae396 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-04 | 193 | 64 | 4 | 9c16032bc03df8760ae199e8f19fdafa4c3f1827 | |
| ToppCell | 368C-Lymphocytic-NK_cells-Proliferating_NK_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.71e-04 | 193 | 64 | 4 | 5f5904cec8b2967154ef2eab3c48f51df53aca4a | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-04 | 193 | 64 | 4 | a4f91bca5eaa985982d33a528f7566ffde154d47 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-04 | 193 | 64 | 4 | b39d7feaac4ff8f7409cd3d15e8f3c6391367275 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.77e-04 | 195 | 64 | 4 | 6477e6e7be5bd8eb99119a12ae16334ccddecd43 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-04 | 195 | 64 | 4 | a1478021a3ed0e779716393124ca2a7770c433b7 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_2_(ZEB2+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.84e-04 | 197 | 64 | 4 | ad6c200a193a15360d17463e18a465ce1b90b8da | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.88e-04 | 198 | 64 | 4 | 31ba87552be97c9b78c9e82f98e96699ccb19824 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.88e-04 | 198 | 64 | 4 | 0a172c6d997c7cfbad34b56e80121bd104dee67d | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.92e-04 | 199 | 64 | 4 | 121de4e02585de3a3010398387c523bacf8ce546 | |
| ToppCell | LPS_anti-TNF-Epithelial_airway-airway_epithelial-Ciliated|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.92e-04 | 199 | 64 | 4 | 15f7814b7074170eee7ccacaa670b1d128fc68bb | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.95e-04 | 200 | 64 | 4 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Pericyte|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.95e-04 | 200 | 64 | 4 | 600d56257b1b0cda8ed2fd0db92c6551711f7d6d | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Pericyte-Muscle_pericyte_pulmonary|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.95e-04 | 200 | 64 | 4 | 8158f4eaeff945a6788c8e732b7a1b0d78052a06 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.95e-04 | 200 | 64 | 4 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Igfbp6_Car10|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 8.07e-04 | 127 | 64 | 3 | f808c727c0817ed10e76eaffa9493a516e9a6b50 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-Mes-Like-Differentiating_AT1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.26e-04 | 128 | 64 | 3 | 2cf0384240a4a663869cf6b27d954236f6214a9a | |
| ToppCell | PBMC-Mild-cDC_4|Mild / Compartment, Disease Groups and Clusters | 9.22e-04 | 133 | 64 | 3 | e53fbd69775a4bff61de82557342f7ac80915c4d | |
| ToppCell | E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal-Intermediate_Fibroblast|E16.5-samps / Age Group, Lineage, Cell class and subclass | 1.00e-03 | 137 | 64 | 3 | dd5364a1002650d21e0c83d8c701b5f7b09d1c19 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Igfbp6_Pltp|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.05e-03 | 139 | 64 | 3 | 9e9f29f92dbe65b26cc78b3a1c00778c6a701f5b | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Mesenchymal-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-03 | 144 | 64 | 3 | 121853910eeea1ea0642b3cc99f9200015480368 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-SMC-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.25e-03 | 148 | 64 | 3 | e514b7cf412ddbee249894e089e2204c67bcdbce | |
| ToppCell | LPS-antiTNF-Epithelial_airway-Ciliated_cells-Ciliated|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.25e-03 | 148 | 64 | 3 | d61123f0c811287843d066b932b4a9ff09c07c5b | |
| ToppCell | LPS-antiTNF-Epithelial_airway-Ciliated_cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.25e-03 | 148 | 64 | 3 | c8e93b87212f55774223caa385859c566fa1981f | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Granulocytic-Neutrophil-Neu_c2-CXCR4(low)|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.33e-03 | 151 | 64 | 3 | b698ddc74565d47892c09c3f16d78038da2dd5e7 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_mature_gamma-delta_T_cell-T_gdT_c14-TRDV2|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.33e-03 | 151 | 64 | 3 | b545823113a3450c5f841f7de48bf0937593544f | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_mature_gamma-delta_T_cell|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.33e-03 | 151 | 64 | 3 | 0cc2f4aec3dae4603fa831f22c40f897e68b34e2 | |
| ToppCell | PBMC-Mild-Myeloid-cDC-cDC-cDC_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.38e-03 | 153 | 64 | 3 | 91e9d70a5d3f6fd68c284ed0cc113f03d7d1e10b | |
| ToppCell | PBMC-Mild-Myeloid-cDC-cDC-cDC_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.38e-03 | 153 | 64 | 3 | f17f62646633cf95c810dcd5328978058741b276 | |
| ToppCell | Control-Epithelial_airway-Ciliated_cells|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.41e-03 | 154 | 64 | 3 | 7556a4b2b062da5ae7ec2bbb66e745e7662db628 | |
| ToppCell | Control-Epithelial_airway-Ciliated_cells-Ciliated|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.41e-03 | 154 | 64 | 3 | 4e3bc24043144143842627cacf6f90dda2228910 | |
| ToppCell | LPS_only-Epithelial_airway-Ciliated_cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.41e-03 | 154 | 64 | 3 | 58072ce422d09f2de602580325eaac6c4ec6c136 | |
| ToppCell | LPS_only-Epithelial_airway-Ciliated_cells-Ciliated|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.41e-03 | 154 | 64 | 3 | 9ca71d440c4f87781e6525b8141e7d8d470b6a8e | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-neuro-epithelial-EC_cells_(NPW+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.43e-03 | 155 | 64 | 3 | 498e52e2364ff44d3c0c707ba22468217031f5bd | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.43e-03 | 155 | 64 | 3 | 5f1e2195a6b831e1b636f5cc3a282ca423721822 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells-Ciliated|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.43e-03 | 155 | 64 | 3 | 0944429459f642a1bcc56edc1ec28aaecde3e2dc | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Myeloid-Macrophage-macrophage,_alveolar-Macro_c6-VCAN|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.43e-03 | 155 | 64 | 3 | d10cf5e922dbd3ca46660404da5aca43f181fc19 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_bronchial_vessel-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.46e-03 | 156 | 64 | 3 | ff39712c7a2dc1b85c598d5105789aa291dea726 | |
| ToppCell | droplet-Heart-nan-24m-Mesenchymal-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-03 | 159 | 64 | 3 | 7ad3a91d29639b32f6264c91f401c14a35469ac0 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.54e-03 | 159 | 64 | 3 | 7ed659163f45e0c4df4782997c0786900c8186c8 | |
| ToppCell | 10x5'v1-week_12-13-Hematopoietic-HSC/MPP_and_pro-HSC/MPP|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.60e-03 | 161 | 64 | 3 | 46b5d80d2d521fb69752aba4c10383e715a32002 | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-3_mon-Neuronal-Cajal-Retzius|3_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.63e-03 | 162 | 64 | 3 | 1f589a763f3fd4e1e612809ef3903879d47dc1d8 | |
| ToppCell | 367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.65e-03 | 163 | 64 | 3 | 63b0badaee3b2d827b1f4524510e3384d8f8fcde | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Gpc3_Slc18a3|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.65e-03 | 163 | 64 | 3 | ec9a20cfe0d69430f9c68cddd1ab0e4a3e4554b8 | |
| ToppCell | P15-Mesenchymal-developing_mesenchymal_cell-mesenchymal_mature_unknown_2|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.65e-03 | 163 | 64 | 3 | e393e5ff885a42b2b44e430d3d5a58f5e50eb732 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Neuronal-Cajal-Retzius|3.5_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.65e-03 | 163 | 64 | 3 | c1484e4de8b10e2f5fb14a7c02b2a015ffe0305e | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex_-18m-Epithelial-neuronal_stem_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.68e-03 | 164 | 64 | 3 | 0853e75b60b2a78257b660910c3ee15b09c5f5b0 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.71e-03 | 165 | 64 | 3 | 436ce4bc75e1ba4351c439ccad19f84ad5bcb92f | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.71e-03 | 165 | 64 | 3 | 242bdb7654f415391fb8e9bdc06412c7eee9c97e | |
| ToppCell | Endothelial-B-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 1.71e-03 | 165 | 64 | 3 | 10087d8bd2985906ef19547fe77eb178ae5e1638 | |
| ToppCell | PBMC-Mild-Myeloid-cDC-cDC-cDC_11|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.74e-03 | 166 | 64 | 3 | b1bebcbe17386cb102b11d551e62d46156ce0c68 | |
| ToppCell | mild_COVID-19_(asymptomatic)-pDC|World / disease group, cell group and cell class (v2) | 1.77e-03 | 167 | 64 | 3 | bf08f17965a4dd03f371b4ed0ab0d5e62ed61307 | |
| ToppCell | PBMC-Mild-Myeloid-cDC-cDC-cDC_11|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.77e-03 | 167 | 64 | 3 | e44743b20a7435c579d8e999ddc4ca119d6753f2 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Hematologic-fibroblast|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-03 | 167 | 64 | 3 | f5bffa77061baec0ba87bd688a047595f32534db | |
| ToppCell | mild_COVID-19_(asymptomatic)-pDC|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 1.80e-03 | 168 | 64 | 3 | 968405ea56f7d001ef83ff9274610923c3b2d55d | |
| ToppCell | mild_COVID-19_(asymptomatic)-RBC|World / disease group, cell group and cell class (v2) | 1.83e-03 | 169 | 64 | 3 | 2bda6ab3f32e05cb7daf91eb7c39b4fcc9ae91bb | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.83e-03 | 169 | 64 | 3 | 335619507857383c3b0b507cdf05d786ed59e585 | |
| ToppCell | facs-Marrow-T_cells-18m-Hematologic-MPP_Fraction_B_+_C|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-03 | 169 | 64 | 3 | 2a35846b0e0be0a19a5a04a86cbd72ce65257c8a | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.83e-03 | 169 | 64 | 3 | 14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.83e-03 | 169 | 64 | 3 | 031465190cd3623a25ef2b868daab8d932c8ff08 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-neuro-epithelial-N_cells_(NTS+)|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.86e-03 | 170 | 64 | 3 | 02f0be0aab8ba2d35a83238609352ef3677511c9 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Epithelial-neuro-epithelial-EECs|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.86e-03 | 170 | 64 | 3 | fcaa32607bcbd8be6f040f9487c3d71e976e1077 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1-3_VIP_ACHE|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.86e-03 | 170 | 64 | 3 | 36dbbdb13f69307afd2122ff051b2980850c1f00 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-fibroblastic-mLTo|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.86e-03 | 170 | 64 | 3 | 7653f1205d4e62abe7e31b1d76f9bbd665e45667 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-6_VIP_VIP|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.90e-03 | 171 | 64 | 3 | a5634b76476b8b2488a706bbab5141f7bd94631f | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1-2_VIP_RPL41P3|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.90e-03 | 171 | 64 | 3 | f6047dee2be0b09ad4d48f97369111bc92e89b35 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.90e-03 | 171 | 64 | 3 | 15cb4670ff4234ac46aea8a5911138d6913c4482 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 1.90e-03 | 171 | 64 | 3 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | LV-13._Vascular_Smooth_Muscle|LV / Chamber and Cluster_Paper | 1.90e-03 | 171 | 64 | 3 | e99ecae66530d1ae09330cee408c8f3950b87e67 | |
| ToppCell | facs-Lung-Endomucin-3m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.93e-03 | 172 | 64 | 3 | b3c4adccc34bb9e4e78e40f4e2e23736c347cc75 | |
| ToppCell | droplet-Liver-Hepatocytes-21m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.93e-03 | 172 | 64 | 3 | 574ebdf36e45222bcd907cd2c2ee7ff50ed4573a | |
| ToppCell | facs-Lung-Endomucin-3m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.93e-03 | 172 | 64 | 3 | 2f1673fcb2356684d60871debb0f159aec553a1c | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.93e-03 | 172 | 64 | 3 | a9e13aa36087170dadca421ba9de588e5a1cf715 | |
| ToppCell | droplet-Liver-Npc-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.93e-03 | 172 | 64 | 3 | a6fb1bde8d942c7b5caaf7bd14de0b7ce32fda55 | |
| Disease | Treacher Collins syndrome (implicated_via_orthology) | 6.27e-05 | 6 | 61 | 2 | DOID:2908 (implicated_via_orthology) | |
| Disease | glucagon measurement, glucose tolerance test | 6.27e-05 | 6 | 61 | 2 | EFO_0004307, EFO_0008463 | |
| Disease | sexual dimorphism measurement | 4.25e-04 | 1106 | 61 | 9 | EFO_0021796 | |
| Disease | blood phosphate measurement | 4.69e-04 | 174 | 61 | 4 | EFO_0010972 | |
| Disease | temporal lobe epilepsy (is_marker_for) | 7.80e-04 | 20 | 61 | 2 | DOID:3328 (is_marker_for) | |
| Disease | Leber Congenital Amaurosis | 9.46e-04 | 22 | 61 | 2 | C0339527 | |
| Disease | Parkinson disease | 9.46e-04 | 22 | 61 | 2 | cv:C0030567 | |
| Disease | attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement | 1.29e-03 | 801 | 61 | 7 | EFO_0003888, EFO_0007052, MONDO_0002491 | |
| Disease | cerebral infarction (is_implicated_in) | 1.65e-03 | 29 | 61 | 2 | DOID:3526 (is_implicated_in) | |
| Disease | intelligence, self reported educational attainment | 1.85e-03 | 117 | 61 | 3 | EFO_0004337, EFO_0004784 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LNSLSEFMDNMSFLD | 1646 | Q96QE3 | |
| EFMDNMSFLDALLTD | 1651 | Q96QE3 | |
| EDNSDMIFMLLTKFD | 1756 | Q9HCE0 | |
| AEAQMLGSADLDDMK | 256 | P48751 | |
| DFAAMEFLDGDSRML | 476 | Q96FN4 | |
| EFEANTMDSLVDMPF | 26 | Q9P0M2 | |
| EDIDQMFSTLLGEMD | 6 | Q7Z5R6 | |
| SDDENFMLLIEQSGM | 396 | A6NC57 | |
| EALIMFDKDNLDDMG | 126 | Q9Y2Z9 | |
| LFQSDAMFEPDMQEA | 721 | Q5JTC6 | |
| FLEDMDSLEDMALLE | 81 | P51861 | |
| FEETSADDFAMEMGL | 146 | Q96CB8 | |
| GSMFDDLADQLDAML | 1416 | Q8WXD9 | |
| INEEAAMFDSLLMDS | 56 | O60684 | |
| DAAADFTLLAMDMPS | 741 | Q6ZRQ5 | |
| MDFSSMDLDDALRKF | 826 | Q5JU85 | |
| LGSDLGDAMSEEDML | 326 | P54252 | |
| EIDLDDEAMEAMFGQ | 2931 | Q15751 | |
| TMALMEEFFLQGDKE | 381 | P54750 | |
| DFTLDDGPFMMNDEE | 26 | P21810 | |
| MDLMDISDQEALDVF | 241 | Q96EV8 | |
| LDFHGAVMRALDDMD | 916 | Q6ZNL6 | |
| ESIILNDFMDSDEMD | 451 | A8MYZ6 | |
| AMHVSMLEGFDENLD | 1456 | O60229 | |
| LNMDESLEEACTMFE | 741 | Q6ZWE6 | |
| LALDEADRMIDMGFE | 341 | Q9UJV9 | |
| ALLDTQDMENMSDDD | 641 | O00410 | |
| LLDFVSMEELNDMDD | 191 | O94880 | |
| ISTMFDALADQLDAM | 1186 | Q8WXE0 | |
| MFSQLADLDDELDGM | 5136 | Q9UPN3 | |
| LGDEAMMALDQSLAS | 781 | Q9BQG0 | |
| EMNAFLDDPEFADIM | 96 | Q8TCG2 | |
| MDDAMDCLMSFSDFL | 126 | Q9H6J7 | |
| DFSDMQMLDGDDGIL | 476 | Q96A23 | |
| FEAEEGLMLAADIMR | 536 | P54257 | |
| SDEDLMDIPATAMDF | 26 | P51795 | |
| LMNLIDCFMDDFADE | 1816 | Q8WXX0 | |
| NDGMVEADDLRSLMF | 2256 | Q8WXX0 | |
| EGDDFNLLLAVTMLM | 886 | Q9BZC7 | |
| SQDMLSIMEKLEFFD | 406 | P05155 | |
| DNLSELLMAMQDELD | 321 | Q8IYX8 | |
| DQMAAELGFDMRLDV | 446 | Q8IYT3 | |
| ADISELFDALMTLEM | 356 | Q9H069 | |
| MDTFADFDTMTDRLL | 1181 | Q49AJ0 | |
| LDLDMFNGSLECDME | 611 | O43524 | |
| LQGAMDDLDADMKEA | 2696 | P46939 | |
| ADDEEMMDQLLRQGF | 916 | O15034 | |
| DFFDIDVIMDILDMN | 76 | O75343 | |
| LRVMEGLDAFDDLMQ | 341 | Q9H7Z7 | |
| MDENSLEFDMVGIDA | 56 | O15160 | |
| LMFLEEMLDGLESLN | 1006 | Q7Z745 | |
| DASQAEMVDFFLALM | 196 | Q8NGX8 | |
| NSDDMSEDLLMDLTN | 131 | A0PJX0 | |
| SSLEDMDALELDFRM | 1471 | O15417 | |
| LMESMAAEEDFEPNQ | 2111 | O15417 | |
| ENLEMNGDSLMFASL | 461 | Q70EL2 | |
| SSADELLLTEMMFNG | 881 | P42285 | |
| DKLFGLFEAMSAIEM | 51 | Q5VZE5 | |
| ISDSMDFVLLNFAEM | 176 | Q96QK1 | |
| DLIFDIDQAMLDMDN | 81 | A6NMA1 | |
| IEDDMLKEEMNGFSS | 131 | Q9P0W8 | |
| LMEDLFETFQDEMGF | 66 | Q9H869 | |
| MDFLADLMDNSELIR | 116 | Q15029 | |
| MAVDSAMELLFLDTF | 1 | Q69YN4 | |
| RLSENAFDLEAMSML | 2236 | P18583 | |
| FNFLASDLMMAVDDP | 586 | O94874 | |
| DAMHLSMLEGFDENI | 1466 | O75962 |